| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | sitagliptin (Januvia®) |
| Formulation | 100 mg film-coated tablet |
| Reference number | 275 |
| Indication | Treatment of patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin or a PPAR gamma agonist when diet and exercise, plus metformin or a PPAR gamma agonist, do not provide adequate glycaemic control
|
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Endocrine system |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 06/12/2007 |